For a 2-year-old with a barking cough and no respiratory distress due to croup, which treatment plan is appropriate?

For a 2-year-old with a barking cough and no respiratory distress due to croup, which treatment plan is appropriate?

• A. Narcotic cough suppressant as needed, fever management, mist therapy, and rest
• B. Antibiotic therapy combined with steroids and an expectorant
• C. Nebulized albuterol and expectorants
• D. Continued use of an expectorant if helpful, oral steroids, mist therapy, and rest

Answer: (D)

Managing mild croup focuses on reducing airway inflammation and keeping the child comfortable while monitoring for any signs of worsening. A single dose of an oral corticosteroid is the key component because it rapidly decreases laryngeal edema and shortens the course of symptoms. Supportive care—adequate rest and fluids—helps the child recover without adding risk. Humidified mist therapy can be offered for comfort, though strong evidence that it changes outcomes is limited. If an expectorant has helped, it can be continued, but it’s not essential to the treatment plan. Antibiotics are not indicated in viral croup, and narcotic cough suppressants are avoided due to risk of respiratory depression in young children. Nebulized albuterol is not routinely recommended unless there is a history of wheeze or underlying asthma.

Managing mild croup focuses on reducing airway inflammation and keeping the child comfortable while monitoring for any signs of worsening. A single dose of an oral corticosteroid is the key component because it rapidly decreases laryngeal edema and shortens the course of symptoms. Supportive care—adequate rest and fluids—helps the child recover without adding risk. Humidified mist therapy can be offered for comfort, though strong evidence that it changes outcomes is limited. If an expectorant has helped, it can be continued, but it’s not essential to the treatment plan. Antibiotics are not indicated in viral croup, and narcotic cough suppressants are avoided due to risk of respiratory depression in young children. Nebulized albuterol is not routinely recommended unless there is a history of wheeze or underlying asthma.